AKT1 and medulloblastoma: The authors demonstrate that heterogenous glioblastoma and medulloblastoma cell lines display cytostatic responses to double combinations targeting mitochondrial glycolysis, the phosphatidylinositol 3‐kinase/protein kinase B pathway, or protein phosphatase 2A.